Health Services (Developing Countries)
(26/01/06)
The Parliamentary Under-Secretary of State for International Development
(Mr. Gareth Thomas):
I am grateful to Mr. Speaker for allowing this debate on strengthening
health services in developing countries.
Achieving better health is vital if the poor are to break out of the cycle
of poverty. We know also that better health is central to the achievement
of the millennium development goals. Three of those eight goals—maternal
health, child mortality, and AIDS and communicable diseases—are directly
influenced by the provision of better health services.
The
truth is that progress is slow, and without an accelerated effort those
millennium development goals will not be met in much of
Africa
during this century. I am sorry to say that there remains a massive health
divide between developed and developing countries. Life expectancy at
birth in the
United
Kingdom is 70 years; in Malawi it is only 35 years. Similar divisions
exist also within countries, where child mortality in the poorest groups
is typically double that among the richest groups.
The
global health statistics remain stark. Eleven million children still die
each year from preventable or readily treated diseases such as measles,
malaria, diarrhoea or pneumonia, and half of them are malnourished. We
know also that 500,000 women die in childbirth, and 99 per cent. of them
are from developing countries.
Despite recent progress with increasing access to antiretroviral
treatment, AIDS remains largely unchecked, and some 25 years into the
epidemic, 5 million people are newly infected with HIV every year, adding
to the 40 million people already infected. About 20 million people have
died as a result of the epidemic. Sadly, 120 million women still have no
access to reproductive health.
Malaria, tuberculosis and other communicable diseases remain a major
concern, but developing countries face a double burden of disease. Chronic
diseases are linked also to lifestyle choices such as diet, smoking and
exercise. Those are becoming increasingly important. For example, it has
been estimated that tobacco use will have been the likely cause of 10
million deaths every year by 2020.
Better health clearly depends on progress in many areas, including
economic growth.
David Taylor (North-West Leicestershire)
(Lab/Co-op): The Minister mentioned malaria. The World Health Organisation
has made it fairly clear that using monotherapies over a long period can
build up resistance, which makes them much less effective. Have the
Government taken that into account in their investment in tackling malaria
in its various forms?
Mr. Thomas:
I am grateful to my hon. Friend for that intervention. It allows me to
confirm the substance of his question, and to point to the £10 million
being committed over the next five years to the Medicines for Malaria
Venture, one of the bodies looking at resistance to malarial drugs. It is
considering the new drugs that are available and what we can do
collectively to spread best practice in treating the disease.
As I
said, economic growth is important to better health. Education,
particularly of women, is equally important. Access to safe water and
sanitation, dealing with social exclusion and challenging gender
inequality, too, will contribute to better health. However, accessible and
high-quality health services are particularly important in places with a
high burden of communicable diseases, where health conditions affect
mothers and children and where people have limited access to basic care.
Investment in those high-quality services will make the most profound
difference.
We
know from World Bank research that we could reduce child mortality by up
to two thirds and maternal mortality by up to three quarters if we could
deliver near universal access to a range of available, proven and
affordable health interventions and commodities.
The
continuing health divide is a threat to us all in a globalised world. A
communicable disease respects no international boundaries, as AIDS and
severe acute respiratory syndrome have shown most recently. Following the
temporary withdrawal of the polio vaccination in
Nigeria
back in 2004, the virus spread rapidly to 18 previously polio-free
countries as far away as Yemen and Indonesia. Today, people are rightly
concerned about the rapid spread of avian influenza to Europe and its
potential to trigger a human pandemic that could kill many thousands of
people.
The
threats of unchecked population growth have largely fallen off the
international agenda, but inevitably they, too, remain a concern for those
of us who are considering the need for better health services. We believe
that by 2050 the global population will rise to 9 billion from 6.5 billion
today.
Ms
Sally Keeble (Northampton, North)
(Lab): Does my hon. Friend accept that although there might not be the
same threat of population explosion, the need for reproductive health
services continues because of the need to protect people against
HIV/AIDS and to ensure
that there is proper birth spacing, so that women can recover from births,
be healthy, look after their children and protect their health, too? Does
he therefore agree that although the immediate threat might have gone, the
need for the services is as great as ever?
Mr.
Thomas:
My hon. Friend is right. We need substantially to improve access to
services to promote maternal health for the reasons that she outlined. The
support that is being given to women for proper birth spacing, for
example, is not as good as we would like it to be, and it is nothing like
the support that is given in the developed world. Part of our effort to
increase the quality of basic health services in developing countries must
be directed to better maternal health.
The
continuing rapid population growth will make it harder to invest in key
social sectors such as health and education, so we also need to continue
to focus on that. A newcomer to international health may sensibly conclude
that it should be straightforward to strengthen basic health services.
After all, we have long known about these health problems, and we have
proven, effective and often low-cost interventions for most of them. We
know that health workers, often with only limited training, can deliver
many of those interventions outside a formal health setting, but we also
know that they remain massively underused, particularly by the people who
are most in need.
The
truth is that health systems in developing countries face many challenges.
They often face severe and long-term underfunding, and in some cases they
have to deal with a deteriorating infrastructure, unreliable or inadequate
supplies of essential drugs, as my hon. Friend the Member for North-West
Leicestershire (David Taylor) said, weak institutions and governance, and
increasing shortages of trained health workers, particularly in the rural
under-served areas, a point that was brought home graphically to me when I
visited Malawi with the Minister of State, Department of Health, my hon.
Friend the Member for Doncaster, Central (Ms Winterton).
David Taylor:
Will the Minister pay tribute to a charity in Leicestershire, staffed at
least in part by people from North-West Leicestershire, called Inter Care,
which collects surplus medicines and matches them to specific requests
from partner health units in Africa? He talked about rural areas. Many
rural clinics have the staff to deliver essential basic health care, but
cannot afford or obtain essential medicines and basic equipment, while
medicines that are of perfect quality but are unwanted are being destroyed
in
Britain.
The charity recycles medicines to a number of English-speaking countries
in Africa. Is that not the sort of initiative that can help the main
thrust of what our Government are doing?
Mr. Thomas:
I pay tribute to the work of Inter Care. My hon. Friend's intervention
proves that non-governmental organisations can play a role when the
capacity of Governments to provide those health services is not what we
would wish for. However, we have to continue to work towards a situation
in which the work of an organisation such as Inter Care is not necessary
and we have developed health services to such an extent that we do not
need to recycle the drugs not needed in developed countries.
Where
health services are available, the poor often cannot overcome the
financial barriers posed by user fees. AIDS, which has reached every
country on the planet, is undermining efforts to improve health and
reversing the development gains of recent years. There are a number of
critical barriers to progress to which we need to direct our attention if
we want basic health services in developing countries to improve
substantially.
We
have to start with finance. The World Health Organisation estimates that
it would cost only approximately £20 per person to provide an essential
package of services to deal with the major causes of ill health.
Ministries of Health in many low-income countries typically spend less
than £5 per head; that is a pretty daunting gap. When we consider that
much of that spend benefits the better-off urban populations, that too
little is spent on primary care and that, by contrast, the UK NHS budget
is nearer £1,300 per head, we get some sense of the scale of the financial
challenge.
We
need a step change in funding from domestic budgets and international
assistance. We need to train and hire staff to ensure a constant supply of
life-saving drugs and to enable health workers to reach unserved
communities—in short, we need to provide the fuel that keeps a health
service running. We also know that aid needs to be longer term and more
predictable, rather than in the form of the multitude of short-term
projects that we often see.
Ideally, that long-term, predictable assistance should be provided in
Government budgets. When services are provided, too many of the poor are
precluded from using them because of prohibitive costs, which can push
families into crippling debt and intractable poverty. When the Government
in
Uganda
removed formal user fees, attendance at health facilities doubled from 6
million to 12 million over a 12-month period. UK budget support to Uganda
has helped the Government there to fund their priorities within that
national health plan.
Achievements as a result of that budget support include a doubling of the
budget for essential drugs, the recruitment of an additional 2,700 primary
care workers, the doubling of doctors' salaries and the construction of
482 health centres. As a result of that investment, national immunisation
coverage increased from 41 per cent. of the Ugandan people in 1999 to 89
per cent. in 2005—a huge step change. Although it is too early to
demonstrate improved health outcomes in
Uganda,
more people are clearly able to access better-resourced services than was
the case.
Sadly, many developing countries do not prioritise health in their
national development plans and budgets. There are a few exceptions, such
as
Sri
Lanka and Kerala state in India, which have demonstrated a significant
commitment to expanding access to services and to equity and
accountability. They have achieved some impressive outcomes. For example,
child mortality in Kerala is now 19 per 1,000 people, while the figure is
138 per 1,000 people in Madhya Pradesh.
Our
second challenge is to deal with the mounting crisis in staffing health
services. Trained health workers are in short supply in many low-income
countries. Poor conditions of service and poor prospects have led many to
leave the health service to work in other countries or sectors where
pastures appear greener. We need to expand training opportunities and find
imaginative solutions to retain staff and encourage deployment to
under-served areas—rural areas, in particular.
The
expansion of our own health service and an ageing population have
contributed to the trouble by attracting many nurses to the
UK.
However, we are working closely with the Department of Health to address
that. Many countries are revisiting the use of mid-level workers and
training them to provide services that have traditionally been provided
only by doctors or senior nurses. In Mozambique, for example, there are
now nurse obstetricians while, in Malawi, there are clinical officer
anaesthetists. The problem of recruiting health workers from developing
countries does not face only the United Kingdom, but Organisation for
Economic Co-operation and Development countries in general. By 2015, the
United States alone will need an additional 1 million health workers and
will inevitably try to import them from other countries. Many countries in
Europe
face the same challenges. It is undoubtedly a global issue that will
require global solutions.
We
need to work with all providers of health care in developing countries,
such as in the public sector and in the third sector that was highlighted
by my hon. Friend the Member for North-West Leicestershire. The
information and commodities that can improve health are usually delivered
through a range of formal, as well as informal, providers. Faith-based
organisations, for example, have a long history of providing services in
under-served areas. Non-governmental organisations have a strong presence
in many countries, particularly in sub-Saharan
Africa
and in much of Asia.
The
private sector is also a major provider of services in many countries.
However, it is often unregulated, separate from the mainstream and works
outside of the Government's plans. Many services are provided informally
in small shops that stock a few key medicines and by traditional
practitioners. While Ministries of Health in developing countries must
provide the overall framework to achieve better health for the population
as well as monitoring progress, often they cannot be the main service
provider. There is a need to exploit all the opportunities that exist in
developing countries to deliver services.
One
obvious example is the social marketing through NGOs that has long
provided most of the world's contraceptives and is now an important
provider of insecticide-treated nets. The private sector is being
increasingly drawn in by Governments as a partner as a result of
contracting out the delivery of district-level services, leading to a
doubling of the use of health services in
Cambodia
and to the franchising of reproductive health services in Pakistan.
Ms
Keeble:
Does my hon. Friend recognise the important role played by the private
sector in occupational health services? For example, Anglo American has
tested all its staff for
HIV/AIDS
and provided services not only to its employees, but to families and
communities.
Mr. Thomas:
I join my hon. Friend in paying tribute to the work of Anglo American.
Several large multinational corporations in
South
Africa
have set an example for the private sector in testing provisional
antiretrovirals in respect of their work force and the communities that
they serve more broadly, helping to deal with
HIV/AIDS.
We need more private companies to be willing to follow that lead, but
Anglo American has certainly done an important, helpful job.
Another barrier is the weak voice of civil society and the poor
accountability of health service providers to the people whom they are
trying to serve. Sadly, no Government of a developing country have fallen
because of their failure to provide health services, yet often when we
talk to the poor in developing countries it is their health and the
catastrophic expenditure that they will have to face when dealing with
serious illness in their families that is of major importance to them. We
need to support civil society to demand more of their Governments on
health care and to be more willing to hold them to account.
We
also need to deal with weak performance management. With a few exceptions,
efforts to monitor performance and demonstrate the results of investment
in health have been inadequate and ineffective. More effective information
systems will be vital if we are to help match resources to the delivery of
results, and to continue to argue for mobilising additional resources in
the pursuit of better health services. There are many challenges and
debates on how we can best channel aid. In settings where the health
system is very dysfunctional, there are particular attractions in using
targeted approaches to deal with the major diseases, and there have been
some impressive gains in past years as a result of such approaches. For
example, smallpox was eradicated in 1997, and polio is expected to follow
in a few years.
David Taylor:
It is possible for even a small organisation to have a really significant
and disproportionate impact on health care. An organisation in
Leicestershire provides support to a total of about 2.5 million people in
rural communities in Cameroon, Ghana, Malawi, Tanzania, Uganda and Zambia.
So it is not just the size of the organisation that counts, because an
organisation can lever in and catalyse activity in its own region and
country.
Mr. Thomas:
My hon. Friend is right that NGOs, regardless of their size, can make a
huge contribution in addressing the gaps in health care provision in
developing countries. I pay tribute to those British and international
NGOs based in his area that are working in sub-Saharan
Africa
and elsewhere.
One
of the most significant targeted investment in recent years has been on
AIDS, TB and malaria—three key poverty diseases. There have also been
significant reductions in child mortality in very poor countries such as
Tanzania, Malawi and Mozambique, again through approaches that
deliberately target the major childhood diseases.
However, we need to recognise the limits of focusing on single issues, and
we need to ensure that it is not done to the detriment of efforts to
strengthen the broader health system. We might prevent deaths from measles
through targeted vaccination programmes, but the child that benefits from
that programme may then succumb to malaria because there is no constant
supply of an effective medicine. The same health worker who delivers AIDS
education could deliver malaria treatment, vaccination programmes or
maternity care programmes. Those health workers need to be enabled to
deliver the full health package. We have learned in recent years that if
we are to have a lasting impact, we need to address the problems affecting
the whole health sector, rather than just specific parts of it.
The
UK has a long and distinguished history in international health work which
goes back as far as the 19th century and the establishment of the School
of Tropical Medicine in Liverpool. We remain at the forefront of
international health policy, maintaining a substantial investment in
health in poor countries. In recent years, many new global partnerships
have emerged, such as the Global Alliance for Vaccines and Immunisation
and the Global Fund to Fight AIDS, Tuberculosis and Malaria, which are
partly based on British expertise. They have helped to raise the profile
of, and rejuvenate efforts against, particular diseases, and they have
helped to raise significant additional resources for health at a time when
overall aid levels had declined globally. Also, the private sector has
become more engaged with health and philanthropic foundations—notably the
Bill and Melinda Gates Foundation—which provide more funding for health
than many UN agencies.
Health probably has a higher international profile than ever before. It
has been the subject of discussions in the UN General Assembly, and of
course last year at the G8 summit and during our presidency. It is one of
the obvious recipients for some of the extra $50 billion of aid that was
agreed at Gleneagles. We have to ensure that those additional funds are
spent on the right things and target those most in need. As I said, that
aid needs to be long-term and predictable. Only then will countries have
the confidence to scale up their health services and invest in the
necessary training, and only then will they have confidence that they can
recruit and pay for additional staff at the same time as revitalising
their health infrastructure. Only when there is that long-term,
predictable aid will Finance Ministers and Health Ministers have the
confidence and ambition that we want them to have for health care spending
in their country.
It is
important that we find the right balance between targeted investment
through specific funds and long-term investment in systems-building. We
must ensure that targeted approaches, such as the global fund, complement
the broader effort to develop health systems, rather than undermine or
divert resources away from it.
As
hon. Members know, our aid budget is committed to rise to 0.7 per cent. of
gross national income by 2013. In the interim period, we are still looking
for innovative ways to front-load investment into health and education.
One powerful example is the international finance facility for
immunisations, which will provide an additional £4 billion to the global
immunisation efforts over the next 10 years and will, we believe, save
some 5 million lives in the process. A larger international finance
facility is under development and is expected to channel significant
support to health and education. With our European allies, we are
exploring a number of innovative approaches to increase aid. We are also
considering how we can stimulate investment by the pharmaceutical industry
in a new generation of drugs and vaccines, through advanced market
commitments.
In 2005,
G8 leaders committed themselves to trying to secure universal access to
AIDS prevention treatment and care by 2010, which is an ambitious goal
that will require rapid attention to the systems-wide constraints. In
post-conflict and fragile states, we will face particular challenges in
building even basic health systems from scratch.
We
are trying to work with other donors to simplify the international system
for health and AIDS. Too many agencies—be they UN, World Bank, or the
various global funds or bilateral donors—are working in developing
countries, often with unclear and overlapping mandates. Many of those
agencies deal with specific disease areas, without engaging with the
broader health system on which they all depend. They operate in a
competitive global funding environment in which country-level needs are
often only poorly articulated. With OECD colleagues, we need to try to
hold those various agencies to account for their performance in providing
more and, crucially, better aid. We have to support countries' efforts to
achieve the universal access to AIDS services that they want, as well as
making progress on the child and maternal health MDGs.
The
UK makes a substantial investment in health, through a wide range of
instruments. When we are satisfied with a country's policy environment and
governance standards, we provide direct support to its budget to implement
its poverty reduction plan. However, in other settings, where we do not
have confidence in the policy environment and the commitment of leaders to
reform, we work with a variety of partners to support country-led efforts
to address the whole sector plan, through pooled funding. In fragile
states, for example, we employ project approaches implemented by a range
of partners, particularly NGOs and private sector organisations.
Of
course, we work closely with other Departments, such as the Department of
Health and the Foreign Office. Our country efforts are complemented by a
substantial research agenda, our current priorities being AIDS and other
communicable diseases, reproductive health, maternal and child health,
future concerns—about tobacco, for example—and some of the things that are
more neglected internationally, such as mental health.
We
are supporting a number of public-private partnerships that aim to
increase access to health services or seek to fund research into future
generations of vaccines, such as the international AIDS vaccine
initiative, or the Medicines for Malaria Venture. Better health has to be
at the core of the international development agenda as we look forward to
the next 12 months.
Sadly, progress has stalled or been reversed in many countries. Without a
major effort, many of them will not meet the millennium development goals
on health for years to come. The commitments that were made last year hold
out the possibility of making much more substantial progress on health
once again. I look forward to hearing hon. Members' comments on how we
might make the progress that I think all of us want to see.
Mark Simmonds (Boston
and Skegness)
(Con): May I say how pleased I am to be under your watchful eye in this
important debate, Lady Winterton? I congratulate the Minister on applying
for this debate on an important area of international development policy,
and the Speaker on granting it.
The
Minister mentioned the Government's policy of spending 0.7 per cent. of
our gross national income on development aid, which he knows we support.
We support the millennium development goals, including the three that are
specifically relevant to the debate this afternoon, which the Minister
outlined in his introductory remarks. We also support the global fund to
fight AIDS, TB and malaria, although we are disappointed that other
countries and private organisations do not, perhaps, share the UK
Government's enthusiasm, and ours, for that fund, or accord it as much
importance as we do.
We
also share the aspirations that were set out at G8 on the international
finance facility for immunisation, which could make a significant impact
on health care provision in the developing world. There have been past
successes with regard to health in a global context. Smallpox is a good
example, and we all hope that polio will be eradicated shortly.
It is
only fair to put it on the record that since 1997, the Department for
International Development has provided £1.5 billion for strengthening
heath care systems in developing countries, which is worth while and
admirable, and we support it. The
UK was
the prime mover in setting up the high-level forum on the millennium
development goals on health in
Geneva
in January 2004, at which developing and donor countries discussed
concrete actions to increase health service capacity to meet development
goals. Again, we applaud that.
We
welcome the G8 Africa communiqué, which said that people should have
access to basic health care and encouraged countries to drop user fees,
but recognised that that decision can be made only by the Governments of
developing countries. I shall say more about that later.
I
should like to sum up the current situation. We must prioritise the
provision of basic health care services in the developing world. As the
Minister rightly said, one third of the world's poorest people—about 2
billion of them—do not have access to essential health care services and
medicine. Sadly, that enormous problem cannot be solved in a short time.
The
disease crisis in the poorest countries is staggering. The approximate
numbers of deaths per year are as follows: malaria, 1 million; TB, 2
million;
HIV/AIDS, 3 million. Infection and death rates for those
three diseases are continuing to grow. Approximately every minute, a woman
dies as a result of pregnancy and childbirth.
Mark
Simmonds:
I was speaking about the number of women in the developing world who die
as a result of pregnancy and childbirth; it is one every minute, or
529,000 a year. As the Minister said, 99 per cent. of those deaths occur
in developing countries. The World Health Organisation estimates that more
than 10.5 million lives a year could be saved by 2015 by expanding health
care intervention for infectious diseases, maternal and child health and
non-communicable diseases.
Sadly, some recent initiatives have failed to meet their targets, and I
would argue that the "3 by 5" initiative failed significantly. It was
stated yesterday morning at International Development questions that of
the 40 million people with
HIV/AIDS
in sub-Saharan
Africa,
only 550,000 are taking retroviral drugs and receiving retroviral
treatment, rather than the 3 million anticipated in the target. That is a
significant disappointment. The G8 aspirations on
HIV/AIDS
seem a long way adrift. Initiatives such as "3 by 5" require strong health
care systems to be put in place to ensure that antiretroviral drugs can be
delivered. The lack of such systems is often the main reason why targets
have not been met.
Like
the health care burden, the economic burden of epidemics such as TB,
malaria and HIV is enormous. Those diseases are crippling economies,
devastating key sectors of workers and reducing investment that could be
used to stimulate economies and alleviate poverty. The World Bank
estimates that TB costs the average patient three or four months of lost
earnings. Malaria slows economic growth in
Africa
by about 1.3 per cent. a year. When the prevalence of
HIV/AIDS
reaches 8 per cent., the cost in growth for sub-Saharan Africa will be
about 1 per cent. a year.
Good
health care systems would go a long way to meeting many of the millennium
development goals, including improving maternal health and child health,
and meeting targets on disease. Good health care systems would also
contribute to the achievement of other millennium development goals, such
as access to education, as fewer children will be required to drop out of
school to care for sick or dying relatives, or to care for siblings
because both parents have died. There will also be more teachers. It is a
staggering statistic, but in 1999 in sub-Saharan
Africa
nearly 1 million children lost their teachers to
HIV/AIDS.
The
links between pandemic diseases and national security must not be
overlooked. The Minister has recently been to
Malawi.
He will therefore be aware that because of
HIV/AIDS,
troop strength in Malawi has fallen to 50 per cent. of the minimum
capacity needed to guarantee state security. In Mozambique, police
recruits cannot be trained fast enough to replace those who are dying of
AIDS. Strong health care systems are essential to ensure that law and
order can be maintained. I saw that for myself in Mozambique last year.
We
are greatly concerned about some specific problems with regard to the
provision of health care in the developing world. Of course I understand
that the Minister cannot give answers to those problems today. Of course I
understand that the issues are immensely complex and that the Minister,
the Secretary of State and the Department for International Development
alone cannot solve the problems. There must be international consensus and
co-operation to reverse the trends, particularly in many parts of
Africa.
The
first issue is health care fees in the developing world. The British
Medical Association has calculated that abolishing user fees for health
care facilities could prevent approximately 233,000 child deaths annually
across 20 African countries. User fees are in place across most
sub-Saharan African countries. Initially they were introduced to tackle
severe underfunding, but clear evidence now demonstrates that such fees do
not generate much revenue, significantly deter people from seeking access
to health care, are unlikely to improve efficiency, and disproportionately
affect poor people who require health care most. Will the Minister explain
what steps the Government are taking to encourage developing countries to
abolish their fees? I am aware that there have been successes, but further
work needs to be done to ensure that basic health care will be free at the
point of delivery for all those who require it.
The
second issue is drug availability. The Department for International
Development needs to do more to encourage the pharmaceutical industry to
allow the manufacture of generic drugs for use in the developing world.
The former director general of the World Health Organisation's HIV
programme suggested the designation of a humanitarian corridor within
which leading drug manufacturers would allow rivals to produce drugs at
low prices for modest royalties. Does the Department support that
suggestion? If not, why not, and if so, what is it is doing to encourage
the proposal?
There
is also great concern about the number of medicines being developed to
tackle diseases that predominantly affect poor people. The drugs for
neglected diseases initiative has estimated that less than 1 per cent. of
new drugs coming on to the market are related to tropical diseases. Does
the Minister think that the Department could do anything to increase that
percentage, to ensure that there will be more of the research and
development that is required to increase the number of generic drugs
available to the vast populations who suffer from those diseases? It is
not just a matter of the availability of drugs. Once the drugs arrive in
the developing world there must be adequate facilities for transporting,
storing and distributing them, including reliable refrigeration, transport
and sufficiently trained staff. All those areas are currently lacking.
The
hon. Member for North-West Leicestershire (David Taylor) made a point
about drug resistance, which is becoming prevalent, particularly with
malaria. There is concern that malaria parasites have developed resistance
to the cheapest and most common drugs used to treat the disease.
Resistance to treatment can be delayed by using therapies that combine
different medications. However, currently 18 pharmaceutical companies are
producing and distributing drugs that risk exacerbating drug resistance
and jeopardising the fight against malaria. That needs to be dealt with,
or the problem will only get worse. I understand that that problem is more
prevalent in
Asia
than in
Africa.
There
are also problems with tariffs—internal tariffs between African countries
as well as tariffs that raise taxes on imports into
Africa.
Those, unbelievably, still apply in some instances to basic health care
products such as malarial bed nets, which can significantly reduce the
transmission of malaria, in particular, by as much as 63 per cent. As of
2003, 18 countries have reduced or eliminated the taxes and tariffs on bed
nets. I urge the Government to encourage Governments in the developing
countries to go further and introduce legislation, if not to wipe out
tariffs on health care products altogether—particularly the bed nets in my
example. More people would then have access to the health care that they
deserve and require.
The
Minister also mentioned staffing, which we think is a major issue. We
welcome the fact that the Government have signed up to the code of
practice for the international recruitment of health care professionals,
under which both the public and private sectors make it a policy not to
recruit actively in the developing world. However, that does not prevent
doctors, nurses and other clinical staff from leaving
Africa
and other poor countries. About 23,000 leave
Africa
each year, not necessarily through active recruitment but through what is
termed the "vacuum effect". They are pulled to the developed world—to the
prospect of better conditions and better earnings, and we can all
understand that.
Malawi
has just 100 doctors and 2,000 nurses for a population of 12 million
people, 15 per cent. of whom suffer from
HIV/AIDS.
However, we must balance such facts by understanding remittances and the
important role that they play in alleviating some of the severe economic
problems in poor countries. In the British NHS over the past three years,
the number of full-time clinical academics has been reduced by 14 per
cent. That will further increase the national health service's dependence
on overseas recruitment in forthcoming years. I hope that the Minister and
his counterpart in the Department of Health will put that at the forefront
of their discussions.
It is
essential that all groups in the community have access to health care,
especially women and the poor. For that to happen, however, there must be
better co-operation and co-ordination between public, private and NGO
initiatives. As the Minister rightly pointed out, there needs to be a
degree of certainty that the money is going where it is intended to go,
and much greater control of duplication, as well as cross-country and
cross-organisational co-ordination to ensure the best use of the money
available. For example, TB is responsible for up to half of all AIDS
deaths in
Africa,
so there needs to be greater collaboration and co-ordination between TB
and AIDS programmes. As we heard earlier, a strong civil society is also
essential to the maintenance of good health care.
I
have a few final questions for the Minister. I do not necessarily expect
him to answer them today, but I should be grateful if he gave them some
thought. If he does not respond within a certain time scale, I shall fire
off a letter in the usual way just to nudge him. Although aid and debt
relief are necessary, economic development and international trade offer
the best hope of sustainable solutions to poverty in
Africa
and elsewhere in the developing world. Like everyone else, we were
disappointed by the outcome of the World Trade Organisation meeting in
Hong Kong, particularly because one of the key commitments of the
millennium development goals is to create an open and non-discriminatory
multilateral trading system. At the moment, we are a very long way from
that.
The
reform of trade rules is essential if
Africa
is to trade its way out of poverty and to create the capital necessary to
invest in its health care systems itself, through its own Governments. We
urge the Government and DFID to continue to work for a resolution to the
Doha round of trade talks. They must strike a balance to ensure that
freeing up trade does not necessarily exclude African and other developing
nations from generating revenue through modest tariff barriers. Those
nations can then spend that on public services, particularly health care,
so that they move away from dependency on aid, donations from the
developing world and direct budgetary support.
On
budgetary support, there is a balance between maintaining the continuity
of funding necessary for recipient Governments to guarantee income flows
and thus the provision of services, and ensuring that British taxpayers'
money goes where it is intended to go. As the Minister is aware, the
Conservative party is concerned that at the moment, quite a lot of
anecdotal evidence—I shall not put the percentages on the record—suggests
that a significant percentage of budgetary support money is unaccounted
for and does not end up where it is intended to go.
I
would like the Minister to think about putting in place more stringent
transparency and accountability procedures, to ensure that direct
budgetary support from the British taxpayer goes where it is intended to
go. Of course we understand that there is a balance to strike between
ensuring both that there is transparency and accountability and British
taxpayers get value for money, and that the recipient Government are
democratically accountable for the money that they get. At the moment,
that balance is not necessarily correct.
On
debt relief, we welcome the heavily indebted poor countries initiative,
which has benefited a number of countries so far, although we believe that
it could go wider and deeper. However, the G8 debt deal will provide less
than $l billion extra this year for vital services such as health care.
Will the Minister tell us what percentage of the debt relief agreed at G8
will be spent on the provision of health care in developing countries?
Serious questions are now being asked about whether the promises that were
made will be delivered on.
Germany
has gone on record as saying that it is highly unlikely that it will meet
the targets that it thought that it would. What impact will that have on
health care in the developing world? What steps is the Minister taking to
ensure that money from debt relief is used in the recipient countries
specifically to alleviate poverty and on health care, in the context that
we are debating?
The
Minister gave a fair and articulate introduction to the debate. As he
said,
Africa
is struggling with many diseases, not just the three big killers that I
have talked about, and may prove to be the weak link in preventing bird
flu, especially as the rift valley, which runs 9,000 km from Syria in the
north to Mozambique in southern Africa, attracts millions of birds each
year. Indeed, Tanzania has gone on record as saying that it has only
$120,000 to spend on strategies to prevent bird flu. Have the Minister and
his Department made any assessment of the risk caused by Africa's
inability to finance prevention measures, particularly against bird flu?
If, so, what is their reaction? Will funds be allocated specifically to
allow African countries to prepare for the potential global pandemic? I
accept that there is a degree of uncertainty about that.
Economic growth is impossible if a country's population is dying, so
strengthening the provision of health services must be a focus for all our
efforts. Tomorrow, I am travelling to
Yemen to
discover how Oxfam has improved basic health care services in a district
there by enhancing community participation, piloting community financing
and strengthening district health services. Schemes such as those, which
include civil society, NGOs, regional governments and donor country
Governments, must be replicated where appropriate if we are to see lasting
improvements in the health care services of developing nations, which all
of us, across the House, want to see, as those are essential building
blocks for alleviating poverty and improving lives in developing
countries.
Greg Mulholland (Leeds,
North-West)
(LD): I might not be able to stay for the winding-up speeches, as I
promised to attend an event in Leeds. If that turns out to be the case, I
apologise and assure hon. Members that I will read the speeches in
Hansard.
I
want to talk about the recruitment of health professionals from developing
nations, which the Minister and the hon. Member for
Boston
and Skegness (Mark Simmonds) mentioned. The code has been tightened up,
but there is clearly a loophole that needs to be closed. Private agencies
can still perfectly legally recruit health professionals from countries on
the banned list if they do not work in the NHS in the first instance. They
often work in private nursing homes and care homes instead, and frequently
do not do the jobs for which they were trained. Their skills are entirely
wasted, never mind not being utilised in their country of origin, where we
all agree they should be. Private homes sometimes make money from the
practice, which is scandalous. They charge a fee so that they can put the
health professionals through the process and then, after the allotted
period, people are naturalised, live here and are eligible to work in the
NHS. It is clearly recruitment from banned countries by the back door, and
we need to hear more about that from the Minister.
Why
does the Department of Health still leave it to NHS employers to monitor
the code rather than do it itself? I realise that that question is not
directed at the Minister's Department, but I hope that it will be
considered jointly by the two Departments. The Department of Health should
monitor the code and not leave it to self-regulation, which could lead to
a conflict of interest among NHS employers. As for figures in connection
with the loophole, I am sure the Minister accepts that between 2004 and
2005, 3,301 health professionals joined the
UK
register who were from banned countries. Although the code is welcome and
has made the position better, it is not working sufficiently. I hope that
the Government will give it serious consideration.
There
is a more complex problem, and I am not suggesting that we have a solution
to it. It is creditable that the Government are investing in
Malawi.
It is hugely welcome work and we thoroughly support it, but what is the
Department's assessment of the effect that it is having on attracting
health professionals from neighbouring countries? I am not criticising the
work, but Malawi is the focus of DFID funding, and that is likely to suck
in health professionals from neighbouring countries. The Department and
the Government need to deal with that and the situation needs to be
monitored. That is not simply a theory. It happened in Botswana, where the
Bill and Melinda Gates Foundation put a lot of money into services. It
attracted health workers from neighbouring countries, such as Angola,
where there is a crisis in the health service.We must accept that the
impact of development is often more complicated than we would expect it to
be. Sometimes, development work distorts local labour markets. We must be
aware of that and do whatever we can to ameliorate the position.
We
welcome the overall thrust of the debate. We are all happy to be involved
in it. We shall support any action that the Government take to strengthen
health services and will assist them in finding solutions to the problems.
Ms
Sally Keeble (Northampton,
North)
(Lab): I am pleased to take part in the debate. Although my remarks might
seem critical, I support the Government's action. I recognise the enormous
financial commitment that has been made and the expertise and thought that
have been put in. It is partly because the
United
Kingdom
Government have been so active in such matters that the debate is
developing. One of the reasons why we are pressing the Government is that
they can make a difference and affect what happens in the countries that
many of us care so passionately about.
I
shall discuss three issues. The first is the need to make sure that when
we consider health care systems in developing countries, we look into both
acute care systems and community health care systems. Secondly, we need to
track funding from the global fund down to community-based clinics. I have
spoken to my hon. Friend the Minister about that and today I shall talk
about one project in which I have a particular interest. I do not mean a
financial interest; I mean that I have seen the project's work and am very
much committed to it. Thirdly, I shall talk about maternal and infant
mortality, because that is the subject of one of the millennium
development goals on which the international community is lagging. We are
also lagging on the MDGs on infectious diseases and
HIV/AIDS
reduction.
On
primary care systems, I thought that rather than talk about statistics, I
might recount what I saw when I went to
Africa
with my Schools for Africa project before Christmas. I went to see the
distribution of boxes for children in a slum called Kiandutu, just outside
Nairobi. "Kiandutu" means jiggers, which are horrible little biting
things, and if hon. Members saw the slum, they would know why it was
called that; it is a truly appalling place. I went with my friends from
KENWA—Kenya Network of Women with AIDS—to the house of a woman called
Tabitha, who had a three-week old baby.
Tabitha is HIV-positive and is on antiretrovirals. It was thought that her
baby was probably okay, as far as anyone could tell, because the birth had
been made as safe as possible, but one of Tabitha's other children was
very ill. One of the main routes of transmission is mother to child, and
there is a big need to block off that type of transmission. Once the birth
has been made safe, the next thing is to make sure that the mother does
not breastfeed, so a lot of effort was being put into making sure that
Tabitha did not breastfeed her child. She was keen to avoid doing so,
because she obviously wanted to make sure that the baby lived.
KENWA,
which, as my hon. Friend the Minister knows, is connected to the global
fund, gave the woman some powdered milk. KENWA had to give the baby
ordinary powdered milk because there is no powdered infant formula
available.
Kenya,
which is a big, sophisticated country, is not the only country affected by
that lack of supply. HIV-positive women who are trying to avoid
breastfeeding their babies in order to save their lives do not have access
to supplies of powdered infant formula. It is available only in
westernised shops, and it is too expensive for them.
Another problem was that there was no water. Supplies of water were being
sold, but they were expensive and Tabitha did not have any money. In
addition, the water was not safe for a small baby, so KENWA gave her
bottles of sterilised water. However, there was no fuel, either, so
nothing could be heated up and the mother could not sterilise the bottle.
Although KENWA told Tabitha to feed the baby with a cup and spoon—one can
do that with a little baby—she thought that it was proper to feed the baby
with a bottle, even though it was an unsterilised bottle left all day in a
filthy little hut. At least clean water was used—we hope—but there was no
proper nutrition.
KENWA
put massive effort into trying to make sure that that woman fed her baby
safely. It supplied the powdered milk, which it had difficulty getting,
and the water, and it tried to help her to manage the sterilisation issue.
The woman, who is on antiretrovirals, had to struggle because she had
three other children to look after, including one who was very sick. She
had to cope with all the difficulties that I have described to do
something that we do quite routinely.
I was
struck by the fact that it is well within the capability of the donor
community to make sure that such problems are dealt with. I thought back
to when I had my own children in Guy's hospital just across the river.
Because it is expensive to sterilise bottles, the hospital provides women
who choose not to breastfeed their babies with little disposable bottles
with the formula already made up. You may have seen them, Lady Winterton.
They have a disposable teat, so the whole lot is thrown away after one
feed. Of course, there must be an agreement with the producers that they
do not sell them in supermarkets, or any efforts to encourage women to
breastfeed their babies will be completely on the skids because those
little things are so convenient. Instead, if one so chooses, one can buy
small one-feed cartons of ready made-up formula in supermarkets and
chemists. They are completely sterile: one simply opens them and put the
contents into a bottle and away you go.
I
described them to my friends from KENWA and asked whether they had seen
them and whether it would help to solve part of the challenge of
persuading a woman not to give up the unequal struggle—persuading her not
to breastfeed her baby and risk finding that the baby is HIV-positive.
They did not even know that such products existed—they had never seen or
heard of them. They did not know that they were possible.
I know
that there are all sorts of debates about Nestlé milk. We talk about
giving mothers antiretrovirals, making childbirth safe and trying to block
transmission, which is the biggest problem, but unfortunately everything
comes down to what was happening in that little hut and the woman who was
facing the problem of how to feed her baby safely and avoid the baby
becoming HIV positive.
Real
thought must be given to how we draw the lines that need to be drawn
between acute services, primary services and community-based services.
That is as much an issue for this country as it is for the developing
world. It is extremely problematic for us to deal with. It is just as
important for us in this country, when we talk about improving health and
health care systems, to consider the areas that produce the biggest change
in health care.
I
turn to the problem of tracking the money. KENWA was running a project in
that slum, as well as seven others in
Nairobi
and the surrounding area. The global fund considers KENWA a model
organisation. If one asks the global fund about its work on
community-based projects, it will hold KENWA up as an example. KENWA does
not receive money from the global fund, although it did for a few years. I
pay great tribute to the DFID office in Nairobi for helping KENWA through
a difficult patch by providing it with funds, but it worries me that we
pay a vast amount of money—I forget the exact amount, but the Government
are rightly proud of it—into the global fund and the money is not tracked.
After a great deal of unpicking, I finally found out what had happened.
The
global fund provided the funds for KENWA for three years. Then, because
the Kenyan Government had their own plan, the fund was supposed to go
through the Kenyan Government, who were to decide where the money should
go. In fact, the money went to the Kenyan Government and stopped. I
understand that it is not known what will happen now, because of the
problems in which the Kenyan Government find themselves. Meanwhile, the
staff at KENWA have not been paid for several months, and the organisation
is in crisis.
My
hon. Friend the Minister might say, quite rightly, that KENWA is one
organisation among many and that it is not right to use an Adjournment
debate to lobby for one organisation, but let me explain why this
particular organisation is so important. I did not realise until quite
recently that KENWA provided support for 2 per cent. of all the people in
Kenya
who are on antiretrovirals. Because of the horrors that await those people
if the funding comes to an end and they have no antiretrovirals, the
organisation has been trying to find other programmes in which to put
them. Some have migrated to the Government hospitals, which cannot do the
outreach work that KENWA does. KENWA works in the slums, and is good at
doing such work. Although the Kenyan Government figures for treating
people with antiretrovirals might look good, the reality is that that
great capacity is at risk of being lost as a result of the basic problem
of getting the money from the donors—all credit to them—to those who spend
the money and deliver the services.
Secondly, in addition to those on antiretrovirals, KENWA supports and
feeds 1,400 orphans, and arrangements have not yet been made for the
future feeding of those children. As my hon. Friend the Minister knows,
caring for
HIV/AIDS orphans is a major problem. I have been extremely
concerned for some time about what will happen to such children,
particularly given the risk of infection with
HIV/AIDS
and other health problems if they are not properly supported and
maintained.
The
hon. Member for
Boston
and Skegness (Mark Simmonds) spoke about tracking the money through the
system and ensuring that all the benefits that the UK taxpayer and the
individual donors who provide support expect are delivered. I do not blame
the global fund for the problems—they are the result of a series of
circumstances—but the problems certainly need to be unpicked. That story
is a reminder of the vulnerability of health care systems in countries
where governance is fragile.
My
hon. Friend the Minister was right to say that that things have improved
in many health sectors. The Government, DFID, NGOs and donors can take
great credit for the amount of work that has been done and the outstanding
progress that has been achieved. However, as my hon. Friend said, in some
areas things have not improved, and in some they are getting worse,
particularly infant and maternal mortality rates.
I am
greatly concerned that although it is recognised that things are getting
worse, the attention of the international community has not focused
clearly enough on those indicators and on what health care is needed to
tackle them. There are a number reasons for that. One that springs to mind
immediately is of course the problems of women. Women come very low in the
pecking order under many Governments, especially those of developing
countries. Women and children are treated as a job lot. If the health care
for women is not good, you can bet your last dollar that the health care
systems for the children will not be good. I remember hearing a doctor in
Soweto saying that the failure of the mother predicates the failure of the
child. It is that simple.
In
Kenya, the women are fed well because doing that means that they will be
able to look after their children. I puzzled long and hard about the
practice, which I have seen in a number of countries, of putting people on
antiretrovirals for six months. It was done for only six months because
after that there were no more drugs, but people said that it was terrible
and asked what was to happen then; if people have a second course, the
reaction is even worse. The response is, "If we can keep the mothers alive
for a year or two, that will give the children protection for that much
longer and a better chance later." It was as simple as that.
The
professionals in developing countries and the
UK
who have to deal with such problems often say, "We know what has to be
done and about the interventions needed to make a birth safe. We know what
kind of facilities we need. That stuff can be done, but it is a question
of will." The UK Government can make a real difference; they can make the
arguments and encourage and cajole the rest of the international
community, including the Governments of developing countries, to give such
issues a higher priority.
Some
things are making the situation worse. One is
HIV/AIDS:
we know that the disease has a female face and, increasingly, it is a
young female face. We also know that the biggest form of transmission in
many areas is now said to be from mother to child. There is also the issue
of the number of orphans and what happens to them. I have often spoken to
my hon. Friend the Minister about such issues; the figures are truly
shocking. Just before Christmas, I went to
Zimbabwe
as well as Kenya. I had always thought that there were about 900,000
orphans, mostly
HIV/AIDS
orphans, in Zimbabwe, but I learned from a UNICEF book that the number of
orphans in Zimbabwe was now 1.2 million, and the person at the UNICEF
mission in Harare responsible for child health said that the figure was
closer to 1.5 million, out of a population of about 12 million or 13
million. The implications of providing care for those children in years to
come are startling. The hon. Member for Boston and Skegness has already
pointed to the economic cost of
HIV/AIDS—the
costs incurred if health care systems are provided.
We
must also consider the profound impact of conflict on the health of women
and children because of their position as refugees and as victims of abuse
by combatants, and because of the destruction that conflict causes to
whatever health systems already exist. Changing sociological
factors—changing patterns in child care, adult lives and family
structures—have left children more vulnerable at different stages of life.
Previously birth was particularly dangerous; later, weaning becomes so.
Finally, there is the unresolved problem of the status of women. The
UK Government have pressed on that issue, but the message needs constant
reinforcement. I have seen women in
Bangladesh
who had to wait several days in labour until their husbands came to give
permission for them to be taken to hospital because of complications
during birth. That can simply be too late.
This
is a slight diversion, but my hon. Friend the Minister talked about the
improvements in
Mozambique and seemed to link them with the need to make sure that there
is work with community-based care workers. He is absolutely right to say
that community-based care is important—not just the community care centres
of the type that I saw in Kenya, but home visiting services, which are
desperately important, especially for supporting
HIV/AIDS
victims in the community. It is important that the people who go out are
properly equipped. In quite a few countries, I have seen people go into
the community to provide care without the equipment they need. I met some
midwives in a very rural area of Sudan, who had been given training and
care packs by the DFID, but a couple of years on, all that was left was
the drum for hearing babies' heartbeats—they had lost everything else and
had one of those between them. The supplies need continually to be sent
down the supply chain.
In
Mozambique, I walked with a community care worker around some of the
semi-rural slums in a town called Xai-Xai in
Gaza
province, just north of the capital. There were good roads, so there
should have been good access for people to get in. I walked up a path to a
hut from which the most awful moaning was coming. Inside, a woman was
dying of AIDS. She was simply lying on the floor, because everything else
had gone. All her family was dead. Her child was dead. There was just her
and a care worker from Kuvumbana, the organisation that I was working
with. The carer was there just to comfort the woman; she did not even have
any basic painkillers.
If we
are serious about providing care in the community, we need to ensure that
people are properly trained and have proper supplies that are replenished.
We also need to make sure that there is some joining up of provision. Not
only did the carer in Xai-Xai not have painkillers, but the project had
only intermittent supplies even of food. The supplies that were needed to
make care in the community effective were not there. All the structures
were in place, including a storage room to keep the stuff in, but things
were simply not joined up.
I
should just like to say something relating to what is specifically needed
for health care services. We are focusing on things that are normally
bottom of the pile, as it were, in terms of focus for government
attention. I fundamentally disagree with the hon. Member for
Boston
and Skegness on one point. He said that he thinks that economic growth and
trade is a way to resolve sub-Saharan
Africa's
problems. Of course, economic growth and trade are needed, but sound
policies for redistribution of wealth and service development have to be
developed along with that if we are to tackle the kind of problems that
the Minister talked about, which we all know exist in sub-Saharan Africa.
I
have to say that thinking there is some simple solution sells the problem
short. If the hon. Member for Boston and Skegness wants one example of why
it is not just a matter of economic growth, he need only look at China,
which has the fastest economic growth anywhere in the world, by a long
shot, and is recognised as a future economic superpower.
Mark Simmonds:
Let me clarify. That is not the point that I made. Economic growth through
trade can make a serious contribution, but that alone cannot alleviate all
of the many problems that exist in sub-Saharan
Africa.
The
hon. Lady is right to mention
China,
where there has been extraordinary economic growth, but not all of the
population of China has been dragged out of poverty. Many rural parts of
the far west of China have the same level of economic affluence—or lack of
affluence—as Burma.
Ms
Keeble:
I shall press this matter a little further, because the details have to be
spelled out. It is no accident that that is happening in China. It is
happening because
China
does not have any policies to redistribute wealth, for example, in terms
of sensible tax policy, and it does not have a regional development
policy, so it has no means of getting proper transfers from the
overdeveloped east of the country to the underdeveloped inland areas of
the west. There are major difficulties there. We see
China
taking jobs from this country, while we have to support and develop its
health care systems, particularly on
HIV/AIDS.
Mark Simmonds:
I do not agree with that last point. That is not the reason for disparity
of economic growth in China. The fundamental reason is that in the east of
the country there is a free market and free trade, and in the west there
is still Communist control. That is the fundamental reason for the
disparity in economic growth.
Ms
Keeble:
If the hon. Gentleman asks the Chinese Government what regional and
economic development policies they have and how they plan to tackle the
unequal growth in different areas, they cannot do that. The same is true
of the way in which their economy is growing and the way in which they
develop their services. There are gaps in their policy development. That
is why it is so important that when we talk about strengthening health
care services in sub-Saharan Africa we consider the problem in terms of
the policies that are being developed and how those countries will be able
to effect change.
We
cannot apply simplistic solutions—we cannot think, "One, two, three:
economic growth leads to an end to poverty," although of course the one is
not possible without the other. We must also consider the areas that will
not be touched in hundreds of years by trickle down.
Infant and maternal mortality have been shown to be the most difficult
problems to solve. Tackling them involves looking at some of the most
complex policy areas and prioritising them. Will my hon. Friend the
Minister ensure that those areas receive the attention that they need? In
particular, will he study the problem of tracking funding, and ensure that
the UK Government's enormous financial, policy and service delivery
contribution includes giving proper priority to attention to services on
the ground?
John Barrett (Edinburgh, West)
(LD): The hon. Member for Northampton, North (Ms Keeble) made an
interesting speech and gave us a good reason for strengthening the health
services of developing countries. We need only look at facilities in this
country to see what could be. Some people say that our facilities could be
improved, but we should compare what we have across the road and in my
city of
Edinburgh
with what some of us have seen first hand in developing countries.
Like
the hon. Lady, I had first-hand experience in the
Sudan,
where I spoke to nurses who worked for Médecins sans Frontières. They said
that they often had to put young mothers back together again after they
gave birth, following Caesarean operations done with a spear. That can be
compared with what I saw recently in the Edinburgh Royal infirmary, where
my daughter, who now has a young baby—I am a proud grandfather—had
first-class facilities. There were problems, but the care was expert. Why,
through bad luck, should there be two patients to a bed in children's
wards in some parts of the world—sometimes with a child under the bed on
the floor—while we have expert staff and equipment in spotless hospitals?
It is simply because those children live in some of the poorest countries
of the world.
The
health services of the poorest countries are overstretched, underfunded
and understaffed.
HIV/AIDS,
TB and malaria were mentioned by the Minister, the hon. Member for
Boston
and Skegness (Mark Simmonds) and my hon. Friend the Member for Leeds,
North-West (Greg Mulholland). They have left huge scars on the world.
However, the poorest countries, which are least equipped to deal with the
problems, have suffered the most. The problems are well documented, and
the challenge for us is what we—the Department for International
Development, the Government, and the people of this country—can do to
help.
Improving access to retroviral drugs, for example, has an enormous impact
on the health of people in developing countries. Current estimates suggest
that there are 16,000 preventable deaths a day from
HIV/AIDS,
TB and malaria. The impact of
HIV/AIDS,
in particular, is well documented. The harsh reality is that we are losing
the fight against the disease, with 4.9 million people newly infected last
year, the highest number in the history of the disease. Improving access
to antiretroviral drugs is currently making a real difference. It is
helping to turn the tide in the fight against the disease.
TB is
also making a comeback in several nations and in certain parts of the
United Kingdom. I have witnessed how the fight against the disease is
increasingly undermined by poverty, the breakdown of communities and
social problems, such as drug abuse. The highly effective direct
observation of treatment that was devised by TB pioneer Sir John Crofton,
one of
Edinburgh's
most famous sons, has been adopted universally, but more must be done to
ensure that it is implemented effectively. I am sure that there is a
greater role for the international community in that regard. A year or so
ago, I saw at first hand the excellent work that DFID is doing in the
fight against TB in India.
However, there is only so much that the international community can do
without the co-operation of those in charge on the ground, where the
problems are worse. It is hard for the international community to help
developing countries improve their health services when some refuse even
to acknowledge the difficulties that they face on their doorsteps. The
slums of Kibera on the outskirts of Nairobi were well publicised recently
in the film "The Constant Gardener", which dealt with the problem of drug
testing in developing countries. About 1 million people—the population of
Edinburgh and Glasgow combined—live in those slums, yet the Nairobi
Government did not even accept the existence of what was happening. Such
matters did not feature in plans, and the area does not have a fresh water
supply or sanitation. We must press the Governments of developing
countries to accept that they have a key role to play in the fight against
diseases and in the development of good health services.
I
visited an excellent clinic in
Nairobi
at which the staff and health workers were doing a great job. However,
they wanted to move to better facilities across the road. A building
existed, but the Nairobi local authorities had not connected water or
electricity supplies. The doctors told us that they had been waiting eight
years for the building to be connected to supplies. One of the reasons
they were told why they could not be connected was because new hotel
developments were being built in the city centre and needed the water
supply for bedrooms and swimming pools. There must be an acceptance by the
Government that, if they work with other Governments, certain advances can
be made.
I am
sure that the Minister will agree that part of our struggle is forcing
those Governments to do more to help their countries. The international
community and NGOs will be fighting a losing battle for ever if
Governments show a disregard for the well-being of their citizens. I urge
DFID to step up the pressure on those Governments, to force them to help
their own people whenever possible.
Mention has been made of the importance of Governments recognising their
role in recruiting staff. Such practice has often been described as
poaching nurses and doctors from abroad. I had a similar experience to my
hon. Friend the Member for Leeds, North-West when I visited a care home in
my constituency. The care assistants were fully qualified nurses and I was
told that a fully qualified doctor had worked there for a next-to-nothing
wage as a care assistant, until his qualifications were recognised in this
country. Clearly, there is a long way to go. However, given that such
matters have been mentioned by previous speakers, I shall not dwell on
them.
I am
sure that many hon. Members will be familiar with the work of Dr. Gbary of
the World Health Organisation. He is the adviser on human health
resources. His research estimated that 23,000 of the best trained medical
staff leave Africa each year for the developed world. It is a particularly
frightening statistic when we consider that there are only about 800,000
medical staff in the whole of Africa. The hon. Member for Boston and
Skegness referred to
Malawi
and said that, out of 12 million people, there were 100 doctors and an
estimated 2,000 nurses.
To
put such matters into perspective, almost half of the recent 16,000 staff
expansion of the NHS came from the recruitment of health professionals who
were trained outside the United Kingdom and Europe. My hon. Friend the
Member for St. Ives (Andrew George) raised the extreme case of Swaziland,
where, in the past two years, 200 nurses have been trained, and 150 of
them have since moved to the UK. I am sure that the Minister will agree
that those are sobering statistics.
Hon.
Members may be aware of the recent study by the university of London. It
noted that although the serious consequences of a brain drain are
increasingly recognised, the UK's demand for health professionals has
affected the countries of sub-Saharan Africa more than any other part of
the world. That has not been fully appreciated. We cannot hide the
shameful fact that we have played a particularly prominent part in the
process, with an estimated 31 per cent. of our practising doctors having
been trained overseas. That compares unfavourably with rates in other
European countries of a similar size. In France and Germany, for example,
the proportion of practising doctors trained overseas is only about 5 per
cent. I hope the Minister agrees that we have a responsibility to take a
lead in tackling the problem.
We
cannot be surprised that skilled people will want to move in search of a
better-paid job. However, the tragedy is not only that we employ many
skilled medical professionals from countries that desperately need them,
but that when they arrive in this country they often end up working in
lower-paid, lower-skilled jobs.
I do
not want to be unfair to the Government, because they and the Department
for International Development have done an awful lot of good work on the
problem, which is very complex. I acknowledge that efforts to prevent
doctors and nurses from coming to the
UK
will not necessarily prevent them from going elsewhere. The point is that
it is our responsibility, as a major beneficiary of that medical brain
drain, to take the lead in addressing the problem. The real challenge is
to improve conditions back home so that medical professionals want to, and
can, stay in their own country, where they are most needed and will make
most difference. So far we have not done enough, and what we have done has
not had maximum impact. However, I compliment DFID on its work in Malawi.
The £100 million pledged for better health services, better training and
higher salaries for doctors, nurses and other health workers in Malawi has
been a great success.
It is
important to improve awareness and understanding of health issues in the
poorest parts of the world. In just over a week's time, I, along with a
few other members of the International Development Committee, will visit
Sierra Leone to see how a post-conflict country can develop, and develop
its health service, too. That country currently has the highest risk of
maternal death in the world. The vast majority of cases have easily
preventable causes, including infection and obstructed labour. In Sierra
Leone, as elsewhere, part of the problem is the lack of basic health
education. In some areas there is a history of beliefs that it is natural
that some women will die during childbirth. The idea that that is somehow
the price that is paid is clearly outdated and simply not true. The price
is far too high.
In
many areas of Sierra Leone, lack of basic health education results in
pregnant women shunning medical facilities and choosing instead to give
birth at home with the help of a traditional birth attendant.
Consequently, infection, disease and serious complications during birth
are commonplace. There is little point in providing health services if
people do not want to use them or do not understand why they should use
them. Improving the basic understanding of health issues is another thing
that we must address if we are to improve the effectiveness of health
services in the poorest countries.
The
challenge is to improve health services in such countries, and action must
be twofold. We must do all that we can to tackle the serious problems that
the countries face. Antiretroviral drugs, more hospitals, more staff and
better education will all play their part. However, we must not pretend
that we can treat those problems as we would do health issues in this
country. We can spend money on drugs, we can help to halt the exodus of
trained medical staff, and we can help to fund hospitals, but if the
underlying reasons for the poor health of a country are not dealt with, we
will for ever be firefighting.
Hon.
Members will be aware that the greatest advance in health provision in
this country was the advent of universal access to safe, reliable drinking
water supplies. In the long term, no one single thing will do more to
improve the health of people in developing countries than securing a clean
drinking water supply. That would make a huge difference across
sub-Saharan Africa and beyond. I often hear talk about targeting aid where
it will be most effective, and securing that drinking water supply would
be as effective an outcome as we could hope for.
The
basics required for a healthy population are still missing in many parts
of the world. Until we get to grips with such basic problems, we can only
do so much with hi-tech medical equipment and the latest drugs. Crippling
poverty, poor sanitation and lack of clean drinking water are not problems
that can be solved in the hospitals and medical centres.
As
well as support from outside, there must be political will and
determination within developing countries. How often do we see desperate
conditions and non-existent health services in countries with natural
resources, corrupt Governments and high spending on the military and small
arms? Sudan is just one example that comes to mind. We must keep up the
pressure on such Governments so that the good work done out in the field
by DFID, NGOs and many others is not cancelled out by the actions of the
very Governments with whom they should be working.
David Taylor (North-West Leicestershire)
(Lab/Co-op): I am grateful to be able to make a brief contribution to the
debate, in which I shall flesh out the points that I made in my
interventions.
Here
we are in 2006, 100 years on from the formation of the Labour party, whose
presence in Government we now enjoy. I have been a member of that party
for well over a third of its life. Could its founding fathers and the
other people in that upper room ever have envisaged that we would reach
the present position in international development from what was then the
empire of Great Britain in Africa, Asia and elsewhere? Could they have
envisaged that 100 years later there would be a Labour Government with a
solid and substantial majority and a good track record over nine years on
international development issues? That is a serious achievement. Two of
our most talented colleagues have been Secretaries of State for
International Development: my right hon. Friends the Members for
Birmingham, Ladywood (Clare Short) and for
Leeds,
Central (Hilary Benn).
The
target of 0.7 per cent. of GDP is substantially within reach. The debate
is about strengthening health services in developing countries, and part
of the money will be used in just that way. Our economy is worth about
£1,200 billion at the moment; 0.7 per cent. of that is about £8.4 billion.
We are not there yet, but we are heading in the right direction. I hope to
live long enough to see resources developed and allocated to health
services, education, and all that comes with that, at 1 per cent. and
beyond; who knows? We have played a big part in moving toward that
objective.
I
intervened earlier because our debates on international development are
rightly sometimes dominated by the potential and activities of big
government—national Governments and international organisations such the
United Nations and the European Union. They are sometimes devoted to the
activities of large multinationals such as the pharmaceutical companies
and large charities such as Médecins sans Frontières, Save the Children
and Oxfam. That is fine—of course the great bulk of development work and
the contribution made by countries such as ours is through such channels.
That will always be the case, but it does not tell the full story.
There
are many small organisations that could play a part and tap into
previously unused resources. They can use energy and ideas, they are
quicker on their feet and more flexible, and they can target their support
effectively. That is why I mentioned the work of Inter Care, based in
Syston, Leicestershire, which I think is in the constituency of the former
Secretary of State for Health, the right hon. Member for Charnwood (Mr.
Dorrell). It is a few miles away from my constituency and some of its
volunteers live in north-west Leicestershire.
Inter
Care is not some informal organisation that does not work within proper
professional guidelines with high standards. The people working in it are
qualified pharmacists who have taken a career break or retired early and
who have worked in Africa and Asia. The purpose of my contribution is to
persuade the Minister, and through him the Secretaries of State for
International Development and for Health, that there is considerable scope
for activities such as those provided by Inter Care.
Inter
Care can contribute simple medicines, equipment and educational materials
to health centres in the six English-speaking countries in sub-Saharan
Africa that I listed earlier. I am talking not of some scattershot
approach, but a targeted one. Each donation is sent directly to specific
clinics whose staff and medical needs are known personally to the Inter
Care team in the UK.
Although organisations such as Inter Care are not in a position to respond
to or donate medicines for emergency or disaster situations, they are able
to help significantly. They support the basic health care provided by
local African medical staff as they try to develop their national health
provision.
Earlier, we talked about the nature of the countries that receive help.
They are often the poorest countries on the planet—the poorest countries
in Africa, Africa being the poorest continent on the globe. If
organisations such as Inter Care were not active, the poorest people in
the poorest country on the planet would have no health care or
pharmaceuticals at all. Those have to be given free, because such people
do not have even the necessary income to acquire medicines.
Where
do the resources come from? They are unused, unwanted but in-date quality
medicines that are returned every day to GPs' surgeries throughout our
land of 60 million people. Inter Care is tapping into only a tiny
proportion of that, but is able to help 2.5 million rural people in the
six countries that I listed. I am trying to encourage the expansion of
such activity, rather than to allow such medicines to be wasted and
destroyed.
Ms
Keeble:
Does my hon. Friend agree that stocks that have to be held by GP practices
and are often disposed of—not necessarily because they are out of date—are
available in addition to those returned drugs? They represent a huge loss
for the NHS, but can be recycled as my hon. Friend describes.
David Taylor:
My hon. Friend is right; enormous amounts of medicines in this country are
incinerated or disposed of in safe ways. What a waste—not only of the
production costs, but mainly of the benefits that would come from their
use elsewhere on the planet. Sample packs unused by GPs are destroyed
every day along with pharmaceutical waste. The small pack sizes that
typify those trials are ideal for the small rural health units supported
by Inter Care, which also benefit from gloves, stethoscopes, face masks
and other items that reps leave with GPs in the UK.
My hon.
Friend mentioned other sources such as batch orders, cancelled orders and
so on. A large pool of material is being wasted, incinerated and set
aside, but it could be used, given the will and the means. What sorts of
medicines? Like us, a poor African patient is entitled to appropriate
medicines of appropriate quality. No one is suggesting that any other
category be utilised.
The
choice of which medicines are sent is made during careful consultation
between the qualified pharmacists at Inter Care and the medical staff at
each clinic. The medicines sent are appropriate to particular needs and
resources and are specifically requested by the clinic concerned. They
must meet high standards, must not be damaged or out of date, and must be
legally recognised as safe and effective in a recipient country. There may
be different standards in operation in other parts of the world.
Of
course, World Health Organisation guidelines are observed at all stages.
They are observed when assembling consignments bound for rural parts of
Africa.
There will be up-to-date information on the dosages, contra-indications
and side-effects and all the things that we in the west would expect as
routine.
I
have made a brief contribution to highlight the work of my constituents
and others in Leicestershire and show that, through partnerships with
local health providers, they are about the regular supplies of essential,
basic medicines to nearly 100 hospitals, clinics, health centres and
dispensaries in six of the poorest countries in
Africa.
Almost half those units receive additional support with essential drugs in
the palliative care of patients with
HIV/AIDS,
about whom we have talked. Inter Care is active in that area as well. Like
the regular consignments, those drugs are sent by Inter Care in response
to specific requests, for as long as its help is needed.
I
shall conclude with one quote from Sister Rosemary, who works at Matai
health centre in Tanzania:
"Inter
Care has helped me for very many years as I have moved about from place to
place in Zambia and Tanzania. All the places have been very short of
supplies . . . but I have always been able to write to Inter Care and ask
for help . . . Even if they do not have exactly what I need, they have
never let me down."
That
is as good a testimony as there can be for a smallish voluntary
organisation, working in a rural part of an east midlands county in the
United Kingdom. That work can be replicated, and more work can be done. We
are just pump-priming at the moment. To be part of that in a tiny way—to
be part of a Government, as a Back Bencher, that is achieving so much in
terms of the development goals that we have played a large part in
shaping—fills me full of pride.
A remote member
of my family, Arthur Henderson, was once leader of our great party. He
would have been tremendously thrilled and excited by the progress made by
our Government, elected in 1997 and hopefully re-electable in 2009-10. We
will be happy to carry forward the goals and improve them. Some of the
greatest achievements that political historians will be able to identify,
looking back on this era in 20, 30 or 40 years time, are the changes that
we have made. We all came into politics to make changes for our
communities, our countries and, in some cases, our globe. This area, along
with others, will stick in the memory of future generations in this land
and others. We can rightly be proud, without being complacent, of the
successes that we have achieved in international development.
Mr. Thomas:
With permission, Lady Winterton, I should like to reply to the many points
made by hon. Members from all parties.
Given
the propensity of the hon. Member for
Boston
and Skegness (Mark Simmonds) to write letters requiring a considerable
amount of reflection, I thought that I would start by dealing with the
points that he made. He rightly talked about the importance of the global
fund and highlighted the fact that as a Government we have doubled our
funding to £100 million for both 2006 and 2007.
Nevertheless, the global fund needs more resources than were pledged at
the September replenishment conference that we held in the UK. Since then,
the American Government have approved more money than had been anticipated
for the global fund, which is enormously important. A further mid-term
review of the global fund will assess its performance and provide the
opportunity to mobilise additional funds. One donor that has not yet
pledged resources is the European Community. Because its budget has only
just been agreed, the details have yet to be worked out, but we hope that
the Community will pledge substantial funding at the mid-term review to
allow the global fund to do even more.
The
hon. Member for Boston and Skegness suggested that "3 by 5", the WHO
initiative, had been a failure. I accept that it did not achieve its
headline ambition by the set date, but I do not see it in those same
gloomy terms. The initiative has catalysed people's focus on a treatment
that is beginning to make a significant difference in sub-Saharan Africa.
In 12 months we saw a trebling of the numbers having access to
antiretroviral treatment, which is important progress. The international
attention that has been given to such treatment, and to what needs to be
done to extend access to it, is hugely important. I accept that the
ambitious target of getting 3 million on treatment by the end of last year
was not achieved, but there is more to do on that front, and I shall
return to th |